ETON MEXC RealStocks
Own real ETON shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:28:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Eton Pharmaceutcials, Inc. (ETON) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $62.02, with a market capitalization of $1.84B and a P/E ratio of 36.82. Over the past 52 weeks, its price has ranged from $14.27 to $70.64. This page covers its latest market performance, valuation, price trends and company information.
$1.84B | |
$63.75 | |
$64.50 | |
$61.53 | |
$63.65 | |
425.58K | |
576.76K | |
36.82 | |
$70.64 | |
$14.27 | |
-- | |
2026-09-30 |
Eton Pharmaceutcials, Inc. (ETON) last closed at $62.02 as of 2026-11-19 00:40:00, down 2.59% ($1.65) from the previous close of $63.65.
During the latest regular trading session, ETON traded between $61.53 and $64.50, with a volume of 425.58K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Eton Pharmaceutcials, Inc. (ETON) moved from $64.35 to $62.02, representing a decline of 3.63% ($2.33).
The stock traded between $57.02 and $70.64 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 894.33 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 84.7%
ETON is currently trading at $62.02, placing it 84.7% of the way from its 52-week low of $14.27 to its 52-week high of $70.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Eton Pharmaceutcials, Inc. (ETON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ETON, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ETON shares and USD.
ETON Shares to USD
1.00 ETON shares = 62.015 USD
Calculations are estimates based on the latest available price and are for reference only.